Navigation Links
2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession
Date:6/3/2009

LONG BRANCH, N.J., June 3 /PRNewswire/ -- The 2009 Pharma ChemOutsourcing Conference & Exhibition attendance is way up again in 2009 and is poised to shatter the attendance record set in 2008. The remarkable success of last year's meeting generated the positive buzz responsible for much of the growth. Attendance for the September 14-16, 2009 event is expected to be about 1000.

Also attracting high attendance is the conference program newly focused on the outsourcing needs of small molecule biotech companies, today's drivers behind much of the growth of the pharmaceutical industry, reports Mark Alexay of Apaporis LLC, the organizer. In 2009, 35 different biotech company chemists are participating as speakers.

The high interest in the new biotech track offers biotech company process and medicinal chemistry, supply chain and manufacturing management personnel opportunity to share their chemical sourcing experiences and strategies. Given the small size of most of the firms, the 35 speakers provide a rare glimpse into the challenges they face to secure external suppliers to do their scale up manufacturing. The track may be viewed at http://www.chemoutsourcing.com/agenda.trackd.php

Biotech participants include speakers from King Pharmaceuticals, Medivation, GPC Biotech, Theravance, Bionumerik Pharmaceuticals, Anthera Pharmaceuticals, Palatin Technologies, Magen Biosciences, Inspire Pharmaceuticals, Geron Pharmaceuticals, Phenomix Corporation and CoNCERT Pharmaceuticals.

The show will take place at the beachfront Ocean Place Resort in Long Branch, NJ. The high end venue affords beach area for nightly barbecues and parties to facilitate informal networking. The show kicks off on Sunday, September 13 and ends Wednesday, September 1
'/>"/>

SOURCE Apaporis LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... (PRWEB) December 24, 2014 The report ... at 19.7% by 2019. It also provides a carefully ... strategies and challenges for the market. , Full Copy ... the report, the global market for cell expansion will ... future. It expects this growth to be driven by ...
(Date:12/24/2014)... AUSTIN, Texas , Dec. 23, 2014 /PRNewswire/ ... solutions company focused on gynecologic disease, announced today ... W. Schuler , Birchview Fund LLC and several ... million of unregistered shares of Vermillion,s common stock ... common stock in a private placement.  ...
(Date:12/24/2014)... SARASOTA, Fla. , Dec. 23, 2014  Rock ... today that it has filed a Clinical Trial Application ... Medicines Healthcare products Regulatory Agency (MHRA) seeking regulatory approval ... its lead molecule, Anatabine Citrate. Contingent on ... to conduct a Phase I trial to assess the ...
(Date:12/22/2014)... Md. , Dec. 22, 2014 /PRNewswire/ ... SYN), a developer of pathogen-specific therapies for ... on protecting the microbiome, today announced positive ... Phase 1a clinical trial of SYN-004, the ... prevention of Clostridium difficile (C. difficile) ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... Meeting to be Held In Paris, MOUNTAIN ... PHST ), a leading provider of software, strategic,consulting, ... announced that it will host its second Pharsight(R),Knowledgebase ... 28,and 29, 2008 at the Hotel Concorde La ...
... Delft University of Technology have witnessed the spontaneous repair of ... at the level of a single DNA molecule. Insight into ... this process can lead to the development of cancerous cells. ... publish an article on this in the leading scientific journal ...
... Takeda San Francisco Inc.,announced today the appointment ... scientific officer. Dr. Haak-Frendscho will be responsible ... including overall research,and preclinical development, process development ... San Francisco is a wholly owned subsidiary ...
Cached Biology Technology:Pharsight Hosts European PKS User Meeting 2Takeda's Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO 2
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:12/3/2014)... Dec. 2, 2014 As part of our ... Technologies is pleased to announce the release of a ... to collect the workforce data that they need. ... been left by existing readers. Many such devices have ... and modern technology. Older models force users to navigate ...
(Date:11/21/2014)... VIEW, Calif. , Nov. 20, 2014 ... higher driver efficiency are piloting the North American and ... number of accidents growing, gesture recognition systems that are ... make a mark in the industry. ... the Automotive Gesture Recognition Market in Europe ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Inception Technologies to Release New Biometric Reader 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... b3c newswire / -  LabRoots Inc. announced today ... site for the scientific community. Beginning today, scientists and ... to begin building relationships with other scientists and increasing ... scientists a place to share their expertise and learn ...
... Maize was domesticated from its wild ancestor more than ... in the Mexico,s Central Balsas River Valley. This ... -- for the presence and use of domesticated maize. ... University and Dolores Piperno of the Smithsonian National Museum ...
... of Conservation International, has been selected to receive ... by the Harvard Museum of Natural History (HMNH). ... Lecture on April 5. Renowned for his ... a conservation priority, Mittermeier is considered an expert ...
Cached Biology News:LabRoots Launches Social Networking Site for Scientists & Engineers 2Researchers find the earliest evidence of domesticated maize 2Wildlife biologist named Roger Tory Peterson Medal recipient, speaker 2
... a chromogenic medium for the detection, ... (except S. thyphi) and total coliforms ... takes a maximum of 24 hours, ... sterilization during preparation and performs a ...
Large-capacity refrigerated incubator chamber holds up to 4 independently-operated shakers. Programmable heat, refrigeration, humidifcation are standard. Photosynthetic operation, optional....
...
... The Pulsed Dynamic Focusing MALDI (PDF-MALDI) source ... samples that do not need online separation. ... Trap LC/MS and Agilents powerful Spectrum Mill ... fast analysis of 2D gel-spot digests. It ...
Biology Products: